Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

H7N9 virus continues to spread; International research team traveling to China to assist

"Two more people in China have died from a new strain of avian influenza, bringing to 16 the number of deaths from the H7N9 virus, and the government has warned that the number of infections could rise," Reuters reports.

18 Apr 2013

GAPPD presents opportunity to meld global, local agendas

"Beyond integration across the two diseases, the [Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea (GAPPD) released by the WHO and UNICEF last week] is an opportunity to meld global and local agendas, giving national governments a comprehensive tool to determine the specific plans, investments, and partners needed to address the unique needs of their countries and achieve the greatest health impact for their citizens," PATH CEO Steve Davis writes in the Huffington Post's "Global Motherhood" blog.

18 Apr 2013

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).

18 Apr 2013

Findings hold promise for development of therapies to fight different viral infections

The human body has the ability to ward off viruses by activating a naturally occurring protein at the cellular level, setting off a chain reaction that disrupts the levels of cholesterol required in cell membranes to enable viruses to enter cells.

18 Apr 2013

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.

18 Apr 2013

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

A new study concludes that approximately half of the prescriptions of Tamiflu during the 2009-10 influenza pandemic went unused in England.

18 Apr 2013

Flunisyn Phase 2a trial data shows positive results in elderly population

Following the widely publicised US Centers for Disease Control and Prevention report in February that the current season's flu vaccine is only 9% effective in the over-65 population, Immune Targeting Systems Limited, today announces positive data from a Phase 2a trial with the Company's lead pan-strain influenza A T-cell vaccine, Flunisyn, in the elderly population.

17 Apr 2013

Albert Einstein College of Medicine joins New York Genome Center

Albert Einstein College of Medicine of Yeshiva University will join the New York Genome Center (NYGC) as its twelfth Institutional Founding Member.

17 Apr 2013

Study exposes unexpected features of why humans sometimes make incorrect decisions

Making decisions involves a gradual accumulation of facts that support one choice or another. A person choosing a college might weigh factors such as course selection, institutional reputation and the quality of future job prospects.

17 Apr 2013

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

A study published today in the European Heart Journal found no evidence that digoxin increases mortality in patients with atrial fibrillation, the opposite of results just published by another group in the same journal analyzing the same data.

17 Apr 2013

Large numbers of ER visits go unreported in calculating hospital readmission rates

A study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and Boston University School of Medicine has found that nearly one quarter of patients may return to the emergency department within 30 days of being discharged from a hospitalization.

17 Apr 2013

COPD phase III study by Almirall and Forest Laboratories announces positive results

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall’s inhaler Genuair® (Pressair™ in the USA).

16 Apr 2013

Reports of H7N9 cases, deaths continue from across China

"Two more people have died in China from a new strain of bird flu, raising the death toll from the virus to 13, state media reported Sunday," the Associated Press reports.

16 Apr 2013

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

The pathogen that we are talking about is called streptococcus pneumoniae. That is a fairly common bacteria and if you did a nasal swab you would find that quite a lot of people have this bacterium living in their nasal passages.

16 Apr 2013

Gates Foundation's programs complement new global plan to prevent 2M child deaths

John Grove, a senior program officer at the Bill & Melinda Gates Foundation, and Gretchen Meller, a program officer at the foundation, write in the group's "Impatient Optimists" blog, "By addressing [pneumonia and diarrhea] together, the [Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea] goes to the heart of the matter: both diseases are caused by a range of pathogens, and no single intervention alone will eliminate either disease.

15 Apr 2013

Published report describes 3 cases of H7N9; Researchers developing quick test, vaccine

A new report by a team of Chinese researchers describing the cases of three people who died of the H7N9 avian flu strain in China "was published Thursday in the New England Journal of Medicine along with a commentary from American health officials, who said the disease 'raises many urgent questions and global public health concerns,'" the New York Times reports.

15 Apr 2013

Athletes with vocal cord disorder inappropriately treated for exercise-induced asthma

Athletes with a vocal cord disorder that restricts breathing are more likely to be misdiagnosed and inappropriately treated for exercise-induced asthma, according to research presented today at the Triological Society's 116th Annual Meeting.

15 Apr 2013

Genetic analysis of H7N9 portrays that virus evolves to adapt to human cells

A genetic analysis of the avian flu virus responsible for at least nine human deaths in China portrays a virus evolving to adapt to human cells, raising concern about its potential to spark a new global flu pandemic.

15 Apr 2013

WHO, UNICEF launch new Global Action Plan to save children from pneumonia and diarrhoea

A new Global Action Plan launched today by the WHO and UNICEF has the potential to save up to 2 million children every year from deaths caused by pneumonia and diarrhoea, some of the leading killers of children under five globally.

15 Apr 2013

Scientists use mouse model to identify novel cell surface marker on mammary gland stem cells

Stem cells are different from all other cells in our body because they retain the remarkable genetic plasticity to self-renew indefinitely as well as develop into cell types with more specialized functions. However, this remarkable self-renewal capacity comes with a price, as stem cells can become seeds of cancer.

15 Apr 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

H7N9 virus continues to spread; International research team traveling to China to assist

GAPPD presents opportunity to meld global, local agendas

FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD

Findings hold promise for development of therapies to fight different viral infections

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

Flunisyn Phase 2a trial data shows positive results in elderly population

Albert Einstein College of Medicine joins New York Genome Center

Study exposes unexpected features of why humans sometimes make incorrect decisions

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

Large numbers of ER visits go unreported in calculating hospital readmission rates

COPD phase III study by Almirall and Forest Laboratories announces positive results

Reports of H7N9 cases, deaths continue from across China

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

Gates Foundation's programs complement new global plan to prevent 2M child deaths

Published report describes 3 cases of H7N9; Researchers developing quick test, vaccine

Athletes with vocal cord disorder inappropriately treated for exercise-induced asthma

Genetic analysis of H7N9 portrays that virus evolves to adapt to human cells

WHO, UNICEF launch new Global Action Plan to save children from pneumonia and diarrhoea

Scientists use mouse model to identify novel cell surface marker on mammary gland stem cells

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in